What type of information is primarily included in the Patient Package Insert (PPI) for medications?

The Patient Package Insert (PPI) is primarily designed to provide critical information about the medication directly to the patient. The most significant aspect of the PPI is the inclusion of side effects and risks associated with the medication. This information is essential for patients to understand not only what benefits they can expect from the medication but also the potential adverse effects that may occur. The PPI aims to enhance patient safety and ensure informed decision-making by providing clear and accessible information regarding what the patient can expect when taking the medication.

While manufacturer information, usage instructions, and ingredient lists can also be components of product labeling and patient information, they do not hold the same level of emphasis and importance in a PPI as side effects and risks. The primary goal of the PPI is to communicate potential health risks and adverse effects, thereby allowing patients to have a comprehensive understanding of their treatment.